The Protocolised Management in Sepsis ( ProMISe ) trial is an open , multicentre , randomised controlled trial ( RCT ) of the clinical effectiveness and cost-effectiveness of early , goal directed , protocolised resuscitation compared with usual resuscitation for patients presenting to emergency departments ( EDs ) in the United Kingdom with early signs of severe sepsis or septic shock .